The analysis of molecular mechanism for IRS-1 ubiquitination by nitric oxide
The analysis of molecular mechanism for IRS-1 ubiquitination by nitric oxide
批准号:
18591517
负责人:
SUGITA Hiroki
金额:
$2.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
(1)一氧化氮对肿瘤细胞IGF-R/1RS-1 /PI3-K/Akt通路和MAPK通路的影响。一氧化氮(NO)供体下调MIAPaCa-2细胞(来源于胰腺癌)的胰岛素/IGF信号,包括IRS-1、Akt和GSK-3。另一方面,NO供体上调Erk 1/2的磷酸化。(2) NO供体蛋白酶抑制剂使IRS-1泛素化完全抑制了NO对MIAPaCa-2中IRS-1蛋白的降解。结果怀疑NO调控了MIAPaCa-2的泛素化和IRS-1蛋白的降解。我们制备了IRS-1延迟突变体的一些结构体,并使MIAPaCa-2表达它们。然后,我们找到了IRS-I蛋白被NO降解的重要位点。(3) NO对肿瘤增殖的影响NO可下调部分肿瘤细胞系的细胞生长。我们进行了稳定细胞系的克隆;MIAPaCa-2过表达IRS-1野生型蛋白,MIAPaCa-2过表达IRS-1显性阴性。过表达IRS-1野生型蛋白的细胞株对细胞生长具有较高的种子率,对NO具有较高的敏感性。另一方面,过表达IRS-1显性阴性的细胞系,细胞生长速度较慢,对NO的敏感性较小。这些结果表明NO通过抑制IRS-1蛋白下调IGF信号。这可能是NO下调肿瘤增殖的机制之一。
英文摘要
(1) The effects of nitric oxide on IGF-R/1RS-1 /PI3-K/Akt pathway and MAPK pathway in cancer cells.Nitric oxide (NO) donor down-regulated insulin/IGF signal including IRS-1, Akt, and GSK-3 in MIAPaCa-2 cells (derived from pancreatic cancer). On the other hand, NO donor up-regulated the phosphorylation of Erk 1/2.(2) IRS-1 ubiquitination by NO donorProtease inhibitor completely inhibited the degradation of IRS-1 protein by NO in MIAPaCa-2. The result suspected that NO regulated the ubiquitination and the degradation of IRS-1 protein in MIAPaCa-2. We produced the some constructs of IRS-1 delation mutants, and made the MIAPaCa-2 express them. Then, we found out the important site for IRS-I protein degradation by NO.(3) The effects of NO on cancer proliferationNO down-regulated the cell growth in some cancer cell lines.We performed the cloning of stable cell lines; MIAPaCa-2 over-expressing IRS-1 wild type protein, MIAPaCa-2 over-expressing IRS-1 dominant negative. The cell line, over-expressing IRS-1 wild type protein, show high seed for cell growth, and greater sensitivity for NO. On the other hand, cell line, over-expressing IRS-1 dominant negative, show low speed of cell growth, and smaller sensitivity for NO. These results indicates that NO down-regulates IGF signal by the depression of IRS-1 protein. That may be one of the mechanisms for the down-regulation of cancer proliferation by NO.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer; report of consecutive three cases
伊立替康与小剂量顺铂(I/low-P)联合化疗治疗转移性胆道癌;
DOI:
--
发表时间:
2006
期刊:
J Hep Bil Pancr Surg 13
影响因子:
--
作者:
[Maehara, N., Chijiiwa, K., Eto, T., Funagayama, M., Uchiyama, S., Nakashima, S., Hidaka, H., Hotokezaka, M., Ohmuraya M, Takamori H, Motomura Y, Komori H, Masuda Y, Chikamoto A, Okuma T, Maeda K, Maeda K, Hosaka S, Hirota M, Sugita H]
通讯作者:
Sugita H
Combined radical retropubic prostatectomy and abdominoperineal excision of the rectum for locally invasive rectal cancer as a less invasive surgery: report of a case.
联合根治性耻骨后前列腺切除术和腹会阴直肠切除术作为一种微创手术治疗局部浸润性直肠癌:病例报告。
DOI:
--
发表时间:
2008
期刊:
Int. J. Surg. 92
影响因子:
--
作者:
[Imamura H, Seyama Y, Makuuchi M, Sugita H]
通讯作者:
Sugita H
radical retropubic prostatectomy and abdominoperineal excision of the rectum for locally invasive rectal cancer as a less invasive surgery : report of a case.
根治性耻骨后前列腺切除术和腹会阴直肠切除术作为一种微创手术治疗局部浸润性直肠癌:病例报告。
DOI:
--
发表时间:
2008
期刊:
Int. J. Surg. 92(5)
影响因子:
--
作者:
[Sugita, H., Egami, H., Yokoyama, Y., Suyama, K, Ogawa]
通讯作者:
Ogawa
Chon JY, Tompkins RC, and Martyn. JAA dipocyte apoptosis after burn injury is associated with altered fat metabolism
Chon JY、Tompkins RC 和 Martyn。
DOI:
--
发表时间:
2006
期刊:
J Burn Care Res 27(3)
影响因子:
--
作者:
[Yasuhara, S, Kaneki, M, Sugita, H, Sugita, M, Asai, A, Sahani, N]
通讯作者:
N
DOI:
--
发表时间:
2006
期刊:
J Burn Care Res 27
影响因子:
--
作者:
[Morine, Y, Yasuhara S]
通讯作者:
Yasuhara S
共 14 条
Proteomic analysis for RTK regulation by nitric oxide and its application to cancer therapy
-
批准号:23592016
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:SUGITA Hiroki
-
依托单位:
Proteomic analysis of the regulation of proteins by NO-induced posttranslational modification and anti-cancer therapy
-
批准号:20591633
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:SUGITA Hiroki
-
依托单位: